Author

G. B. Hutchinson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

E. Phung· 2 shared E. S. Yang· 2 shared J. R. Mascola· 2 shared K. S. Corbett· 2 shared L. Wang· 2 shared O. M. Abiona· 2 shared R. A. Gillespie· 2 shared S. Boyoglu-Barnum· 2 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Phung

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivJun 11, 2020

A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone

B. Zhang, C. W. Chao, Y. Tsybovsky…·P. D. Kwong

This paper develops a nanoparticle platform for displaying trimeric antigens, showing that SARS-CoV-2 spike-LuS nanoparticles induce 25-fold higher neutralizing responses than spike alone.

DOI 10.1038/s41598-020-74949-2

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivJun 11, 2020

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

K. S. Corbett, D. Edwards, S. R. Leist…·Wang

This paper describes the development of an mRNA vaccine (mRNA-1273) against SARS-CoV-2, showing it induces neutralizing antibodies and CD8 T cell responses and protects mice from infection.

DOI 10.1038/s41586-020-2622-0

mousemultiome

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 30, 2020

Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines

S. Boyoglu-Barnum, D. Ellis, R. A. Gillespie…·M. Kanekiyo

Nanoparticle immunogens with four seasonal influenza hemagglutinins elicit neutralizing antibodies against both the head and stem, providing broad protection against diverse influenza strains.

DOI 10.1101/2020.05.30.125179

mouserat

𝕏 PostBluesky